Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 3, 2025Open Access

Interleukin-3 as a Potential Bone Anabolic Agent in treating Postmenopausal Osteoporosis

View Full Paper
Ask AI
Bookmark
Share

Authors

VPVikrant PiprodeSBShubhanath BeheraJKJuilee Karhade

Discussion

Loading...

Member takes

Overview

Experimental findings reveal interleukin-3 enhances bone density in ovariectomized mice, suggesting new treatments for osteoporosis.

Key Points

  • IL-3 treatment effectively preserved trabecular bone architecture and improved bone mineral density in OVX mice.
  • The cytokine inhibited osteoclast differentiation while promoting osteoblast differentiation, reducing bone resorption.
  • MicroCT analysis showed IL-3 -/- mice had reduced trabecular bone, indicating IL-3's essential role in skeletal integrity.
  • IL-3 increased Treg cells without adverse effects on hematopoiesis or vital organs, positioning it as a viable therapeutic option.

Cite This Study

Piprode et al. (2025) studied this question.

synapsesocial.com/papers/689a0c7be6551bb0af8d07c0https://doi.org/10.1101/2025.07.12.664485
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ovariectomy-Induced Bone Loss Varies Among Inbred Strains of Mice2005 · 257 citations
  2. 2IL-3 Differentially Regulates Membrane and Soluble RANKL in Osteoblasts through Metalloproteases and the JAK2/STAT5 Pathway and Improves the RANKL/OPG Ratio in Adult Mice2017 · 27 citations
  3. 3Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow.1994 · 236 citations
  4. 4Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-γ-induced class II transactivator2003 · 316 citations
  5. 5Priming of mouse pre-osteoblasts with Interleukin-3 attenuates TNF-α-induced-inhibition of osteoblast differentiation2025 · 2 citations